Answers are grounded in this paper and cite their sources.
Luminal A, luminal B, basal-like, normal breast like and ErbB2+/Her2+3,4 and recently “claudin-low”5 have been identified as molecular subtypes of breast cancer on microarray-based gene expression and hierarchical clustering analysis; hence the evolution of “molecular classification” with great potential for predicting therapeutic response and a better ability to predict overall survival as well as disease-free survival and therefore make prognostic predictions.3,4
No takes yet. Share an insight, caveat, or question.
Naila Irum Hadi (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: